World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
15120
World Ranking
11825
National Ranking
5086

Victor S. Goldmacher publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Victor S. Goldmacher sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 131 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Victor S. Goldmacher D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Victor S. Goldmacher sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Victor S. Goldmacher is affiliated with ImmunoGen in the United States and specializes in research intersecting medicine, biochemistry, molecular biology, and oncology. Their recent work emphasizes the development of antibody-based therapies and cancer treatment strategies.

The researcher's primary areas of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their subfields encompass:

  • Radiology, Nuclear Medicine and Imaging
  • Oncology
  • Molecular Biology
  • Immunology

Main topics addressed in their research are:

  • Monoclonal and Polyclonal Antibodies Research
  • Glycosylation and Glycoproteins Research
  • HER2/EGFR in Cancer Research
  • Toxin Mechanisms and Immunotoxins
  • Cancer Treatment and Pharmacology

Victor S. Goldmacher has published several scientific papers recently, focusing on bispecific antibodies and antibody-drug conjugates for targeted tumor therapy. Notable publications include:

  • "Beyond ADCs: harnessing bispecific antibodies to directly induce apoptosis for targeted tumor eradication," 2024, Antibody Therapeutics
  • "A bispecific anti-MUC16/anti-death receptor 5 antibody achieves effective and tumor-selective death receptor 5-mediated tumor regression," 2025, Scientific Reports
  • "A bispecific antibody overcomes limitations of prior strategies to achieve effective and tumor-selective Death Receptor 5 (DR5) clustering," 2025, bioRxiv (Cold Spring Harbor Laboratory)
  • "Antibody-drug conjugates in cancer and beyond: progress, promise, and perspectives," 2025, Antibody Therapeutics

Frequent collaborators in their research include:

  • Iosif M. Gershteyn
  • Yelena Kovtun
  • Ravi Chari

The most common venues for their publications are:

  • Antibody Therapeutics
  • Scientific Reports
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Cytotoxic agents comprising maytansinoids and their therapeutic use

    Ravi J. Chari;Victor S. Goldmacher;John M. Lambert;Walter A. Blattler

  • Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processing.

    Hans K. Erickson;Peter U. Park;Wayne C. Widdison;Yelena V. Kovtun

  • Immunoconjugates containing novel maytansinoids: promising anticancer drugs.

    Ravi V. J. Chari;Bridget A. Martell;Jonathan L. Gross;Sherrilyn B. Cook

  • Antibody-drug conjugates designed to eradicate tumors with homogeneous and heterogeneous expression of the target antigen.

    Yelena V. Kovtun;Charlene A. Audette;Yumei Ye;Hongsheng Xie

  • A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation.

    Anna Skaletskaya;Laura M. Bartle;Thomas Chittenden;A. Louise McCormick

  • A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2

    Victor S. Goldmacher;Laura M. Bartle;Anna Skaletskaya;Cheryl A. Dionne

  • Semisynthetic maytansine analogues for the targeted treatment of cancer.

    Wayne C Widdison;Sharon D Wilhelm;Emily E Cavanagh;Kathleen R Whiteman

  • Humanization of murine monoclonal antibodies through variable domain resurfacing

    Michael A. Roguska;Jan T. Pedersen;Christine A. Keddy;Andrew H. Henry

  • SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies.

    Jutta Deckert;Marie-Cécile Wetzel;Laura M. Bartle;Anna Skaletskaya

  • ERADICATION OF LARGE COLON TUMOR XENOGRAFTS BY TARGETED DELIVERY OF MAYTANSINOIDS

    C. Liu;B. M. Tadayoni;L. A. Bourret;K. M. Mattocks

  • Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance

    Yelena V. Kovtun;Charlene A. Audette;Michele F. Mayo;Gregory E. Jones

  • The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal

    Helena L A Vieira;Anne Sophie Belzacq;Delphine Haouzi;Francesca Bernassola

  • Cell killing by antibody-drug conjugates.

    Yelena V. Kovtun;Victor S. Goldmacher

  • Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria

    Damien Arnoult;Laura M. Bartle;Anna Skaletskaya;Delphine Poncet

  • Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins.

    J M Lambert;P D Senter;A Yau-Young;W A Blättler

  • Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion

    ML Grossbard;AS Freedman;J Ritz;F Coral

  • Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.

    M L Grossbard;J M Lambert;V S Goldmacher;N L Spector

  • IMGN853, a Folate Receptor-α (FRα)–Targeting Antibody–Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors

    Olga Ab;Kathleen R. Whiteman;Laura M. Bartle;Xiuxia Sun

  • Synthesis and evaluation of hydrophilic linkers for antibody-maytansinoid conjugates.

    Robert Y. Zhao;Sharon D. Wilhelm;Charlene Audette;Gregory Jones

  • Tumor-Specific Novel Taxoid−Monoclonal Antibody Conjugates

    Iwao Ojima;Xudong Geng;Xinyuan Wu;Chuanxing Qu

Frequent Co-Authors

John M. Lambert
John M. Lambert ImmunoGen (United States)
Jagesh V. Shah
Jagesh V. Shah Harvard University
Guido Kroemer
Guido Kroemer Université Paris Cité
Stuart F. Schlossman
Stuart F. Schlossman Harvard University
Nancy Kedersha
Nancy Kedersha Harvard University
Pierfrancesco Tassone
Pierfrancesco Tassone Magna Graecia University
Salvatore Venuta
Salvatore Venuta Magna Graecia University
Jerome Ritz
Jerome Ritz Harvard University
Catherine Brenner
Catherine Brenner Université Paris Cité
Edward S. Mocarski
Edward S. Mocarski Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Biology or Biochemistry opens up a variety of online educational pathways. Many students now opt for flexible, accredited programs to gain expertise without relocating. For those interested in biology, online biology degrees let you dive into cellular biology, genetics, and more—all from home.

Allied health fields are also accessible online. Aspiring nurses can enroll in online asn programs to earn their Associate of Science in Nursing, a crucial step toward registered nursing roles.

For those drawn to nutrition and wellness, earning a nutritionist degree online can lead to careers in clinical nutrition, wellness coaching, or food science.

Additionally, those considering administrative or leadership roles in healthcare should look for cahme accreditation mha programs, designed to meet industry standards and set graduates apart in hospital management and health services administration.

Exploring these online programs can help tailor your education to match evolving career opportunities in the life sciences.

Best Scientists Citing Victor S. Goldmacher

Trending Scientists

Recently Published Articles